title: Serotonin Reuptake Inhibitor Use During Pregnancy.
authors.affiliation: Center for Drug Evaluation and Research, Division of Psychiatry Products, US Food and Drug Administration, Silver Spring, Maryland2Kenan-Flagler School of Business, University of North Carolina at Chapel Hill.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Miller
authors.affiliation: Center for Drug Evaluation and Research, Division of Psychiatry Products, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Michael C
authors.initials: MC
authors.lastname: Davis
authors.affiliation: Center for Drug Evaluation and Research, Division of Psychiatry Products, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Marc B
authors.initials: MB
authors.lastname: Stone
mesh_terms: D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
chemical_list: D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors